BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 33636496)

  • 21. Generation of an induced pluripotent stem cell line, ICGi029-A, by reprogramming peripheral blood mononuclear cells of a patient suffering from hypertrophic cardiomyopathy and carrying a heterozygous p.N515del mutation in MYBPC3.
    Dementyeva EV; Pavlova SV; Chernyavsky AM; Zakian SM
    Stem Cell Res; 2021 May; 53():102344. PubMed ID: 33892289
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Silencing of
    Dainis A; Zaleta-Rivera K; Ribeiro A; Chang ACH; Shang C; Lan F; Burridge PW; Liu WR; Wu JC; Chang ACY; Pruitt BL; Wheeler M; Ashley E
    Physiol Genomics; 2020 Jul; 52(7):293-303. PubMed ID: 32567507
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A heterozygous MYBPC3 (c. 772+1G > A) mutant human induced pluripotent stem cell line (ZZUNEUi025-A) generated from a male patient with hypertrophic cardiomyopathy.
    Zhao X; Cao J; Li X; Liu M; Liu Y; Dong J; Zhao X
    Stem Cell Res; 2022 Apr; 60():102722. PubMed ID: 35257994
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cranial, axial and proximal myopathy and hypertrophic cardiomyopathy caused by a mutation in the globular head region of the MYH7 gene.
    Díaz-Manera J; Alejaldre A; Llauger J; Mirabet S; Rojas-García R; Ramos-Fransi A; Gallardo E; Illa I
    Eur J Neurol; 2014 Jun; 21(6):e51-2. PubMed ID: 24805292
    [No Abstract]   [Full Text] [Related]  

  • 25. Hypertrophic cardiomyopathy
    Rose J; Kraft T; Brenner B; Montag J
    Physiol Genomics; 2020 Jan; 52(1):15-19. PubMed ID: 31790337
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic predictive value of gene mutations in Japanese patients with hypertrophic cardiomyopathy.
    Chida A; Inai K; Sato H; Shimada E; Nishizawa T; Shimada M; Furutani M; Furutani Y; Kawamura Y; Sugimoto M; Ishihara J; Fujiwara M; Soga T; Kawana M; Fuji S; Tateno S; Kuraishi K; Kogaki S; Nishimura M; Ayusawa M; Ichida F; Yamazawa H; Matsuoka R; Nonoyama S; Nakanishi T
    Heart Vessels; 2017 Jun; 32(6):700-707. PubMed ID: 27885498
    [TBL] [Abstract][Full Text] [Related]  

  • 27.
    Dias GM; Lamounier Júnior A; Seifert M; Barájas-Martinez H; Barr D; Sternick EB; Medina-Acosta E; Campos de Carvalho AC; Cruz Filho FES
    Circ Genom Precis Med; 2021 Oct; 14(5):e003476. PubMed ID: 34555931
    [No Abstract]   [Full Text] [Related]  

  • 28. A novel mutation of the MYH7 gene in a patient with hypertrophic cardiomyopathy.
    Goel N; Huddleston CB; Fiore AC
    Turk J Pediatr; 2018; 60(3):315-318. PubMed ID: 30511546
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Presence of Hypertrophic Cardiomyopathy Related Gene Mutations and Clinical Manifestations in Vietnamese Patients With Hypertrophic Cardiomyopathy.
    Tran Vu MT; Nguyen TV; Huynh NV; Nguyen Thai HT; Pham Nguyen V; Ho Huynh TD
    Circ J; 2019 Aug; 83(9):1908-1916. PubMed ID: 31308319
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypertrophic cardiomyopathy clinical phenotype is independent of gene mutation and mutation dosage.
    Viswanathan SK; Sanders HK; McNamara JW; Jagadeesan A; Jahangir A; Tajik AJ; Sadayappan S
    PLoS One; 2017; 12(11):e0187948. PubMed ID: 29121657
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disease penetrance and risk stratification for sudden cardiac death in asymptomatic hypertrophic cardiomyopathy mutation carriers.
    Michels M; Soliman OI; Phefferkorn J; Hoedemaekers YM; Kofflard MJ; Dooijes D; Majoor-Krakauer D; Ten Cate FJ
    Eur Heart J; 2009 Nov; 30(21):2593-8. PubMed ID: 19666645
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Successful knock-in of Hypertrophic Cardiomyopathy-mutation R723G into the MYH7 gene mimics HCM pathology in pigs.
    Montag J; Petersen B; Flögel AK; Becker E; Lucas-Hahn A; Cost GJ; Mühlfeld C; Kraft T; Niemann H; Brenner B
    Sci Rep; 2018 Mar; 8(1):4786. PubMed ID: 29555974
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Co-inheritance of mutations associated with arrhythmogenic cardiomyopathy and hypertrophic cardiomyopathy.
    De Bortoli M; Calore C; Lorenzon A; Calore M; Poloni G; Mazzotti E; Rigato I; Marra MP; Melacini P; Iliceto S; Thiene G; Basso C; Daliento L; Corrado D; Rampazzo A; Bauce B
    Eur J Hum Genet; 2017 Oct; 25(10):1165-1169. PubMed ID: 28699631
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incident Atrial Fibrillation Is Associated With MYH7 Sarcomeric Gene Variation in Hypertrophic Cardiomyopathy.
    Lee SP; Ashley EA; Homburger J; Caleshu C; Green EM; Jacoby D; Colan SD; Arteaga-Fernández E; Day SM; Girolami F; Olivotto I; Michels M; Ho CY; Perez MV;
    Circ Heart Fail; 2018 Sep; 11(9):e005191. PubMed ID: 30354366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Generation of bi-allelic MYBPC3 truncating mutant and isogenic control from an iPSC line of a patient with hypertrophic cardiomyopathy.
    Warnecke N; Ulmer BM; Laufer SD; Shibamiya A; Krämer E; Neuber C; Hanke S; Behrens C; Loos M; Münch J; Kühnisch J; Klaassen S; Eschenhagen T; Patten-Hamel M; Carrier L; Mearini G
    Stem Cell Res; 2021 Aug; 55():102489. PubMed ID: 34375846
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical outcomes associated with sarcomere mutations in hypertrophic cardiomyopathy: a meta-analysis on 7675 individuals.
    Sedaghat-Hamedani F; Kayvanpour E; Tugrul OF; Lai A; Amr A; Haas J; Proctor T; Ehlermann P; Jensen K; Katus HA; Meder B
    Clin Res Cardiol; 2018 Jan; 107(1):30-41. PubMed ID: 28840316
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intrinsic MYH7 expression regulation contributes to tissue level allelic imbalance in hypertrophic cardiomyopathy.
    Montag J; Syring M; Rose J; Weber AL; Ernstberger P; Mayer AK; Becker E; Keyser B; Dos Remedios C; Perrot A; van der Velden J; Francino A; Navarro-Lopez F; Ho CY; Brenner B; Kraft T
    J Muscle Res Cell Motil; 2017 Aug; 38(3-4):291-302. PubMed ID: 29101517
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The role of three-dimensional speckle tracking imaging derived parameters on predicting outcome of hypertrophic cardiomyopathy patients with MYH7 mutations].
    Zhao J; Wang J; Liu LW; Zheng Y; Wang B; Li WX; Yang F; Kang N; Zuo L
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Apr; 48(4):287-293. PubMed ID: 32370479
    [No Abstract]   [Full Text] [Related]  

  • 39. A Contraction Stress Model of Hypertrophic Cardiomyopathy due to Sarcomere Mutations.
    Cohn R; Thakar K; Lowe A; Ladha FA; Pettinato AM; Romano R; Meredith E; Chen YS; Atamanuk K; Huey BD; Hinson JT
    Stem Cell Reports; 2019 Jan; 12(1):71-83. PubMed ID: 30554920
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypertrophic cardiomyopathy: New pathogenic variant in MYH7.
    Vargas-Ursúa F; Melendo-Viu M; Íñiguez-Romo A
    Med Clin (Barc); 2024 Jun; 162(11):563-564. PubMed ID: 38423942
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.